Data Quality in the Real World: Ensuring Integrity across the Medical Device Lifecycle
|
|
- Jasmin Chandler
- 5 years ago
- Views:
Transcription
1 Data Quality in the Real World: Ensuring Integrity across the Medical Device Lifecycle Moderated by Karen Conway, GHX Panelists: Steven Luxenberg, MD, U.S. FDA CDRH Dennis Black, BD Robert Lynch, Franciscan Missionaries of Our Lady Health System (former) Susan A. Morris, Cerner Corporation Slide 1
2 How Does UDI help create Real World Evidence? By promoting incorporation of UDIs into electronic health information, a vast quantity of untapped real-world data from clinical experience with devices housed in EHRs and other electronic information sources may become available for use in understanding the benefit-risk profiles of medical devices. Slide 2
3 International Medical Device Regulatory Forum 9 December 2013 the benefits of UDI can only accrue if all stakeholders, from the manufacturer to healthcare providers and patients, use UDI throughout their workflow systems. A globally harmonized and consistent approach to UDI is expected to increase patient safety and help optimize patient care by facilitating the: a. traceability of medical devices b. adequate identification of medical devices through distribution and use c. identification of medical devices in adverse events; d. reduction of medical errors; e. longitudinal capture of data on medical devices. Slide 3
4 Learning Healthcare System Source: Institute of Medicine, Better Care at Lower Cost, Slide 4
5 A Continuous Learning System built on Real World Evidence (RWE) Slide 5
6 FDA FDA provides regulatory new regulatory approval based approval on (faster) clinical based trials on RWE Manufacturer markets products based for specific on clinical populations trialsbased on RWE Hospitals evaluate and source products, often based based on RWE on price and and specific clinician patient preference needs Manufacturer designs new product, products/enhancements conducts clinical based on real trials world evidence Corrective action if needed Manufacturer markets product based on RWE Demand signals generated RWE generated on performance in routine clinical practice Product purchased, shipped and received Product consumption documented at point of use with UDI in electronic patient record, registries Slide 6
7 Numerous efforts to generate Real World Evidence (RWE) underway. European UDI regulation also includes strong focus on RWE. Slide 7
8 Case for Quality: Product Quality Outcomes Analytics information to make better purchase decisions that improve patient access to high quality medical devices. Requires accurate, consistent, standardized data capture, reporting and analysis by healthcare delivery organizations Slide 8
9 7 Domains of Product Quality Effectiveness: Device produces the effect intended by the manufacturer relative to the medical condition(s). Patient Satisfaction: Device was perceived to meet or exceed patient expectations of usability and outcome Safety: Device does not compromise the clinical condition or the safety of patients, or the safety and health of users. Reliability: Device system or component is able to function under stated conditions for a specified period of time. Usability: Device minimizes the risk of user errors by patients or clinicians. Compatibility: Device is compatible with related devices or drugs, the use environment or relevant standards. 7 6 Availability: Device is available to fill first request orders. Slide 9
10 MDEpiNet RAPID AUDI Workgroup ELECTRONIC HEALTH INFORMATION Device Identifier Global Unique Device Identification Database GUDID GUDID Device Identifier Additional Unique Device Identification Database AUDI AUDI Device Identifier Claims data EHR Registry Data AUDI is designed to be a resource for clinically relevant (discrete) data. that is not contained in the GUDID. e.g., data in the Instructions for Use Specific to device type, e.g., drug eluting stent, replacement joint, etc. Slide 10
11 Slide 11
12 And now for the experts What will it take to get to the promise of real world evidence and the value of UDI? How do we manage, capture, and use UDI-related data across the medical device lifecycle? Slide 12
13 Slide 13
UDI: Generating Value Beyond Compliance
UDI: Generating Value Beyond Compliance Karen Conway, GHX Bill Mosser, Franciscan Missionaries of Our Lady Health System David Brooks, Medtronic June 7, 2017 Slide 1 2 UDI: What, When, How, Why? Why are
More informationMoving UDI from Regulation to Value Within Hospitals and Beyond
Moving UDI from Regulation to Value Within Hospitals and Beyond Karen Conway Executive Director, Industry Relations, GHX Terrie Reed, MDEpiNet Coordinating Center Duke Clinical Research Institute Slide
More informationCase for Product Quality Outcomes Analytics 26-October-2016
1 Case for Product Quality Outcomes Analytics 26-October-2016 2 Agenda o Who we are and how we fit into Case for Quality o What is quality? o Hypothesis and pilot journey o Key outcomes o Challenges and
More informationUDI COMMUNITY (LUC): RESOURCES AND DELIVERABLES
LEARNING UDI COMMUNITY Advancing Health Care through Supply Chain Excellence LEARNING UDI COMMUNITY (LUC): RESOURCES AND DELIVERABLES Learning UDI Community WWW.AHRMM.ORG/LUC About AHRMM: The Association
More informationRegistry Assessment of Peripheral Interventional Devices (RAPID)
Registry Assessment of Peripheral Interventional Devices (RAPID) Pablo Morales, MD FDA Division of Cardiovascular Devices MDEpiNet Annual Meeting October 20, 2017 RAPID moving into full SPEED Pablo Morales,
More informationUDI in the US. Ms. Terrie Reed, Senior Advisor for UDI Adoption U.S. Food and Drug Administration. 19 October 2017
UDI in the US Ms. Terrie Reed, Senior Advisor for UDI Adoption U.S. Food and Drug Administration 19 October 2017 UDI: Regulatory Update Terrie L. Reed, MS. Ind. Engineering Center for Devices and Radiological
More informationProduct Quality Outcomes Analytics Update
1 Product Quality Outcomes Analytics Update 2 Car Buying Parameters 1 2 Safety. Effectiveness 5 Usability 6 Availability 3 Reliability 7 Compatibility 4 Satisfaction 3 How Do You Buy Your Car? Consumer
More informationFDA s Center for Devices and Radiological Health: Strategic Priorities for 2017 and Beyond
FDA s Center for Devices and Radiological Health: Strategic Priorities for 2017 and Beyond Jeff Shuren, MD, JD Center for Devices and Radiological Health U.S. Food and Drug Administration May 4, 2017 1
More informationUsing Real-World Evidence (RWE) for Regulatory Decision Making and Pracatice. Danica Marinac-Dabic, MD, PhD Director, Division of Epidemiology
Using Real-World Evidence (RWE) for Regulatory Decision Making and Pracatice Danica Marinac-Dabic, MD, PhD Director, Division of Epidemiology Summary RWE context Selected Examples of Early Successes and
More informationClinical Integration Track: It s All About the Data
Clinical Integration Track: It s All About the Data Presenters: Sandi Michel, Director of Systems & Quality The Office of Data Standards & Interoperability Franciscan Missionaries of Our Lady Health System
More informationU.S. FDA CENTER FOR DEVICES AND RADIOLOGICAL HEALTH UPDATE
U.S. FDA CENTER FOR DEVICES AND RADIOLOGICAL HEALTH UPDATE Jeff Shuren Director Center for Devices and Radiological Health CDRH STRATEGIC PRIORITIES UPDATE The Center for Devices and Radiological Health
More informationCRNs as Foundational Blocks of the National Evaluation System for Medical Devices: A Call to Action
CRNs as Foundational Blocks of the National Evaluation System for Medical Devices: A Call to Action Danica Marinac Dabic, MD, PhD Director, Division of Epidemiology Summary FDA Strategic Priorities: 2016
More informationLUC UOU Explained Talk Track
LUC UOU Explained Talk Track (Slide 1): Welcome to the AHRMM Learning UDI Community. This presentation is intended to explain the history behind the introduction of the Unit of Use (also known as the UOU
More informationRegistry Assessment of Peripheral Interventional Devices (RAPID) Used to treat infrainguinal arterial occlusive disease
Registry Assessment of Peripheral Interventional Devices (RAPID) Used to treat infrainguinal arterial occlusive disease Goal: Standardize core data elements that could serve as a global case report form
More informationManagement of Clinically Significant Device Attributes not Contained in the GUDID: Augmented Unique Device Identifier Data AUDI
Management of Clinically Significant Device Attributes not Contained in the GUDID: Augmented Unique Device Identifier Data AUDI Report of the MDEpiNet AUDI Workgroup MISSION: Provide the framework for
More informationEnhancing Laboratory Data Infrastructure to Access Real-World Evidence (RWE) for in vitro Diagnostics (IVDs): Three Models for RWE Use
Enhancing Laboratory Data Infrastructure to Access Real-World Evidence (RWE) for in vitro Diagnostics (IVDs): Three Models for RWE Use Michael Waters, Ph.D. Michael.Waters@fda.hhs.gov Office of In Vitro
More informationReal World Evidence Generation in the 21 st Century: National Evaluation System for health Technology (NEST)
Real World Evidence Generation in the 21 st Century: National Evaluation System for health Technology (NEST) Bill Murray, President & CEO IDEAL Conference Presentation May 5, 2017 1 www.mdic.org Vision
More informationPeripheral Arterial Disease
Peripheral Arterial Disease Registry Assessment of Peripheral Interventional Devices (RAPID) Launched June 5, 2015 Goal Standardize core data elements that could serve as a global case report form for
More informationLUC UOU Examples Talk Track
LUC UOU Examples Talk Track (Slide 1): Welcome to the AHRMM Learning UDI Community. This presentation is intended to provide more information on potential use cases for the Unit of Use (also known as the
More informationIssues in Clinical Trial Designs for Devices
Issues in Clinical Trial Designs for Devices Soma Kalb, PhD Director, Investigational Device Exemption (IDE) Program Office of Device Evaluation Center for Devices and Radiological Health FDA Clinical
More informationUpdate on Real World Evidence Data Collection
Update on Real World Evidence Data Collection STAMP, 10 March 2016 Presented by Dr Peter Arlett EMA An agency of the European Union What is Real-world evidence? Big data = umbrella term describing large
More informationUDI: From Compliance to Value OMTEC June 2013 Karen Conway
UDI: From Compliance to Value OMTEC June 2013 Karen Conway 1 GHX GHX proprietary information: Please do not not copy copy or or distribute UDI: The Reality UDI: The Reality UDI: The Reality UDI: The Reality
More informationRegistry Assessment of Peripheral Interventional Devices (RAPID)
Registry Assessment of Peripheral Interventional Devices (RAPID) Used to treat infrainguinal arterial occlusive disease Goal: Standardize core data elements that could serve as a global case report form
More informationCollaboration: GS1 and Joint Initiative Council (JIC) in Healthcare
Collaboration: GS1 and Joint Initiative Council (JIC) in Healthcare International Organisation for Standardization European Committee for Standardization Health Level 7 international International Health
More informationLUM Best Practices. April 25, Linda Rouse O Neill, HIDA Loretta Chi, FDA Christina Savisaar, FDA Dennis Black, BD Mike Marchlik, Owens & Minor
LUM Best Practices April 25, 2018 Linda Rouse O Neill, HIDA Loretta Chi, FDA Christina Savisaar, FDA Dennis Black, BD Mike Marchlik, Owens & Minor Slide 1 Session Facilitator Linda Rouse O Neill, MA Vice
More informationScott Gottlieb, MD Commissioner of Food and Drugs Food and Drug Administration New Hampshire Avenue Silver Spring, MD 20993
July 31, 2018 Scott Gottlieb, MD Commissioner of Food and Drugs Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 RE: Medical Device Safety Action Plan: Protecting Patients,
More informationDefining the true market
Defining the true market Case study: How real-world data and outcomes improved a major pharmaceutical company s launch strategy Cardinal Health Specialty Solutions Competing in a crowded marketplace A
More informationImportance of Logical Identifiers, Names and Codes (LOINC ) in Developing in vitro
Importance of Logical Identifiers, Names and Codes (LOINC ) in Developing in vitro Diagnostic (IVD) Infrastructure to Support a National Evaluation System for health Technology (NEST) Michael Waters, Ph.D.
More informationUDI in Rapid Phase III: Improve decision making with better UDI data
1 POTENTIAL PROJECT UDI in Rapid Phase III: Improve decision making with better UDI data OVERVIEW IMPACT Objective Methodology Participants Overarching- Use knowledge from earlier RAPID phases to improve
More informationPragmatic Clinical Trials for Regulatory Decisions
Pragmatic Clinical Trials for Regulatory Decisions Jacqueline Corrigan-Curay, MD JD Office of Medical Policy Center for Drug Evaluation and Research FDA May 16, 2018 Pragmatic Clinical Trials Pragmatic
More informationTHE FUTURE OF THE REVENUE CYCLE. A survey of provider executives about the next generation of revenue cycle management
THE FUTURE OF THE REVENUE CYCLE A survey of provider executives about the next generation of revenue cycle management OVERVIEW 1 Survey At-a-Glance 2 RCM Technology Trends/EHRs 3 4 Revenue Integrity Trends
More informationRAPID Phase 1 Deliverables Use Cases, Flow Diagrams
RAPID Phase 1 Deliverables Use Cases, Flow Diagrams James E. Tcheng, MD Duke Clinical Research Institute Durham, NC RAPID Think Tank 14 September 2016 1 Use Cases: Background & Rationale Why Use Cases?
More informationGUIDE HEA
Companies are often overwhelmed by the field of digital health. From digital and med device companies to biotechnology and pharmaceutical companies, there is a struggle to cut through the noise of numerous
More informationPeople-Powered Knowledge Generation
What s Next? People-Powered Knowledge Generation Harlan M. Krumholz, MD SM Harold H. Hines, Jr. Professor of Medicine harlan.krumholz@yale.edu @hmkyale June 1, 2016 The Problem The medical research enterprise
More informationRe: Voluntary 2015 Edition Electronic Health Record (EHR) Certification Criteria: Interoperability Updates and Regulatory Improvements
April 28, 2014 Filed Electronically: http://www.regulations.gov Department of Health and Human Services Office of the National Coordinator for Health Information Technology Attention: 2015 Edition EHR
More informationRE: FDA-2011-N-0090: Food and Drug Administration; Unique Device Identification System
November 7, 2012 Margaret Hamburg Commissioner Food and Drug Administration Department of Health and Human Services Room 2217 White Oak Building One 10903 New Hampshire Avenue Silver Spring, MD 20993 RE:
More informationGS1 Standards in Healthcare
GS1 Standards in Healthcare Contact GS1 Alan Gormley Standards Conformance and Training Manager Tel 01 208 0671 Mob 087 970 5222 email alan.gormley@gs1ie.org GS1 Ireland Second Floor, The Merrion Centre,
More informationIncorporating the Unique Device Identifier (UDI) into Health Care Delivery. Margaret Weiker, President, The Weiker Group
Incorporating the Unique Device Identifier (UDI) into Health Care Delivery Margaret Weiker, President, The Weiker Group Unique Device Identifier (UDI) Unique Device Identifier (UDI) an identifier that
More informationDecember 13, Meeting Summary
December 13, 2012 Meeting Summary Unique Device Identification (UDI) Implementation Expert Workshop: Identifying Steps for Implementation and Integration of UDI within Electronic Data Infrastructure of
More informationHL7 Plenary EHR In Canada
HL7 Plenary EHR In Canada September 11, 2006 Dennis Giokas Chief Technology Officer Canada Health Infoway, Inc Agenda Canada Health Infoway What is the EHR and It s Benefits Architecture and Standards
More informationThe Future of Cancer and Public Health Surveillance A CDC perspective
The Future of Cancer and Public Health Surveillance A CDC perspective Chesley Richards, MD, MPH CDC Deputy Director for Public Health Scientific Services Director, Office of Public Health Scientific Services
More informationAnalytics. HealthView. Cardiovascular Data Intelligence.
HealthView Analytics Cardiovascular Data Intelligence www.lumedx.com info@lumedx.com Meaningful Data for Clinical and Operational Success Cardiovascular service lines are under tremendous pressure to perform
More informationMultiple Device Identifier Work Group Report
LEARNING UDI COMMUNITY Advancing Health Care through Supply Chain Excellence Multiple Device Identifier Work Group Report WWW.AHRMM.ORG/LUC VISION: The concept that a specific type of medical device would
More informationKeynote: Progress on the NEST Coordinating Center
1 Keynote: Progress on the NEST Coordinating Center Rachael Fleurence, Ph.D. NESTcc Executive Director July 20, 2017 The Ecosystem Challenge The health care ecosystem is united behind the need to improve
More informationCase Studies: Sharing Lessons Learned
Case Studies: Sharing Lessons Learned Panel: Dennis Black, Director, e-business, BD Megan Brandt, VP Quality & Regulatory Affairs, Cardiovascular Systems, Inc. David Reed, VP Operations, Cook Medical Esther
More informationWELCOME AND INTRODUCTIONS
S.M.A.R.T. Medical Device Informatics Think Tank Specific, Measurable, Achievable, Results-Oriented, Time Bound Collaboration WELCOME AND INTRODUCTIONS James Tcheng, M.D. Joseph P. Drozda, Jr., M.D. Terrie
More informationRegulatory Science: FDA Paths Forward With Real World Evidence Mitchell W. Krucoff, MD, FACC
Regulatory Science: FDA Paths Forward With Real World Evidence 2017 Mitchell W. Krucoff, MD, FACC Professor, Medicine/Cardiology Duke University Medical Center Director, Cardiovascular Devices Unit Director,
More informationUnique Device Identification. Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration
Unique Device Identification Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration jay.crowley@fda.hhs.gov 301-980-1936 Visibility of Device Identification Manufacturer Medical Device
More informationMay 21, Moderator: Rachael Fleurence, PhD NESTcc Executive Director
The Changing Landscape of Health Care Decision-Making How can we Leverage the use of Real-World Evidence for Regulatory, Coverage, and Clinical Decision-Making? May 21, 2018 M EET YOUR PANELISTS! Moderator:
More informationBipartisan Policy Center, Top Medical Innovation Priorities
Bipartisan Policy Center, Top Medical Priorities FDA: Advancing Medical is a Bipartisan Policy Center initiative led by former Senator Bill Frist, MD, former Congressman Bart Gordon, and BPC Health Initiative
More informationUDI 101: What You Need to Know About Unique Device Identifiers
UDI 101: What You Need to Know About Unique Device Identifiers Lena Cordie Qualitas Professional Services 2015 Qualitas Professional Services. All rights reserved. Presentation Objectives: Understanding
More informationDr. Rachael Fleurence, PhD NESTcc Executive Director. September 22, 2017
Dr. Rachael Fleurence, PhD NESTcc Executive Director September 22, 2017 BUSINESS DAY F.D.A. Seeks to Tighten Regulation of All-Metal Hip Implants By BARRY MEIER JAN. 16, 2013 After an estimated 500,000
More informationUDI: The Ins and Outs of Global Compliance and Value
UDI: The Ins and Outs of Global Compliance and Value Karen Conway Executive Director GHX Jay Crowley Vice President USDM OMTEC 2015 Copyright 2015 by USDM Life Sciences Introductions Jay Crowley VP of
More informationA Coordinated Registry Network Based on the Vascular Quality Initiative: VISION. Vascular Implant Surveillance & Interventional Outcomes Network
A Coordinated Registry Network Based on the Vascular Quality Initiative: VISION Vascular Implant Surveillance & Interventional Outcomes Network Jack L. Cronenwett, MD Medical Director, Society for Vascular
More informationUS Regulatory and Marketing Barriers for Medical Devices
US Regulatory and Marketing Barriers for Medical Devices September 8, 2015 Zvi Ladin, Ph.D. Principal Boston MedTech Advisors Boston Germany Israel 1 Regulatory Barriers Market Barriers (providers / payers)
More informationBalancing Value & Burden: CMS Electronic Quality Reporting
Balancing Value & Burden: CMS Electronic Quality Reporting Session #199, February 14, 2019 Michelle Schreiber, MD, Director, Quality Measurement and Value-Based Incentives Group Debbie Krauss, MS BSN RN,
More informationUsing local RWD to drive global therapeutic advancements.
Using local RWD to drive global therapeutic advancements. Helsinki, 30 th Nov 2016 Mike Spencer, Head of Real World Evidence, EMEA, Janssen The following represent my own views and not necessarily those
More informationWHITE PAPER. Everything You Need To Know About the FDA UDI Rule
Everything You Need To Know About the FDA UDI Rule Basics In creating the UDI system, the FDA aimed to reduce the burden on the healthcare industry by building on systems that are already in place. The
More informationNiccolo Machiavelli (1523)
Nothing is more difficult to undertake, more perilous to conduct or more uncertain in its outcome, than to take the lead in introducing a new order of things. For the innovator has for enemies all those
More informationBuilding the National Evaluation System for Medical Devices
Building the National Evaluation System for Medical Devices The Role of MDEpiNet PPP J. Matthew Brennan, MD, MPH Interventional Cardiology Duke Triangle Heart Associates Assistant Professor of Medicine
More informationGuidance for Industry, Review Staff, and the Clinical Community
Guidance for Industry, Review Staff, and the Clinical Community Guidance on Criteria and Approaches for Postmarket Surveillance Document Issued on: November 2, 1998 U.S. Department of Health and Human
More informationOctober 25, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852
701 Pennsylvania Avenue, NW Suite 800 Washington, D.C. 20004 2654 Tel: 202 783 8700 Fax: 202 783 8750 www.advamed.org Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers
More informationGlobal Medical Device Nomenclature (GMDN) Dr Barry Daniels Technical Lead GMDN Agency
Global Medical Device Nomenclature (GMDN) Dr Barry Daniels Technical Lead GMDN Agency GMDN introduction GMDN website GMDN uses in UDI Get from this: To this? Naming and grouping The role of GMDN GMDN
More informationReal World Evidence how patient groups can contribute and how to engage patient groups in clinical research
Real World Evidence how patient groups can contribute and how to engage patient groups in clinical research ERIC LOW INDEPENDENT HEALTHCARE CONSULTANT CHAIRMAN AMYLOIDOSIS RESEARCH CONSORTIUM UK FOUNDER
More informationOctober 26, Unique Device Identification System (FDA-2011-N-0090) Dear Commissioner Hamburg:
1300 North 17 th Street Suite 1752 Arlington, Virginia 22209 Tel: 703.841.3200 Fax: 703.841.3392 www.medicalimaging.org October 26, 2012 Margaret A. Hamburg, MD Commissioner Division of Dockets Management
More informationEasy EHR Issue Reporting Challenge. June 7, 2018
Easy EHR Issue Reporting Challenge June 7, 2018 On Today s Call Challenge Team: Adam Wong, Office of the National Coordinator for Health IT Marcy Opstal, Office of the National Coordinator for Health IT
More informationRealities of UDI Capture: The Mercy/BUILD Experience
Realities of UDI Capture: The Mercy/BUILD Experience RAPID Workgroup, April, 2016 Joseph P. Drozda, Jr., M.D. Director of Outcomes Research The Mercy/BUILD UDI Strategy Integration of UDI into multiple
More informationRegistry Assessment of Peripheral Interventional Devices (RAPID) Phase II Global Unique Device Identification (GUDID)/ Informatics Work Group Summary
Introduction Registry Assessment of Peripheral Interventional Devices (RAPID) Phase II Global Unique Device Identification (GUDID)/ Informatics Work Group Summary The Registry Assessment of Peripheral
More informationFramework for FDA s Real-World Evidence Program
Framework for FDA s Real-World Evidence Program Jacqueline Corrigan-Curay, J.D., M.D. Director, Office of Medical Policy Center for Drug Evaluation and Research Food and Drug Administration March 15, 2019
More informationBig Data & Clinical Informatics
Big Data & Clinical Informatics Client Overview A leading clinical intelligence company that powers healthcare providers, life sciences and research organizations to make better-informed, more confident
More informationImprove your probability. of success
Improve your probability of success FROM PIPELINE TO PORTFOLIO TO POPULATION HEALTH TM Creating a healthier world will require the industry s best thinking and resources. It will also demand working together
More informationCOCIR/MITA Joint Contribution. EU and US call for input on regulatory issues for possible future trade agreement
COCIR/MITA Joint Contribution EU and US call for input on regulatory issues for possible future trade agreement COCIR and MITA welcome the opportunity to share ideas with the United States government and
More informationFDA s Unique Device Identification Program
FDA s Unique Device Identification Program Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration jay.crowley@fda.hhs.gov 301-980-1936 Device Information Lifecycle Manufacturer Reuse
More informationFDA s Unique Device Identification Program
FDA s Unique Device Identification Program Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration jay.crowley@fda.hhs.gov 301-980-1936 Device Information Lifecycle Manufacturer Reuse
More informationMedical Device Software: A new challenge
Medical Device Software: A new challenge Daniela Luzi and Fabrizio Pecoraro National Research Council Institute for Research on Population and Social Policies, Rome Italy Main issues Q.1 Is a software
More informationGS1 Guide on Unique Device Identification (UDI) implementation
GS1 Guide on Unique Device Identification (UDI) implementation This document aims at providing clarification to questions raised by the industry as well as implementation guidance on the use of GS1 standards.
More informationINVESTIGATIONAL DEVICE EXEMPTION APPLICATION. IDE Title (if title being used)
INVESTIGATIONAL DEVICE EXEMPTION APPLICATION IDE Title (if title being used) Name of Sponsor Investigator, MD X Professor, Department Icahn School of Medicine at Mount Sinai Date of Submission Form version
More informationUniversity Health Network UDI Capture Work Group Case Study
LEARNING UDI COMMUNITY University Health Network UDI Capture Work Group Case Study WWW.AHRMM.ORG / LUC WORK GROUP TITLE: UDI Capture Work Group CASE STUDY PARTICIPANTS Wendy Watson, OR Supply Chain Manager
More informationAccelerating Pre-Market Approval for Medical Devices
The National Academy of Sciences The Innovation Policy Forum Medical Devices Innovation: Opportunities, Threats, and Challenges Accelerating Pre-Market Approval for Medical Devices Michael J. Mack, MD
More informationCDRH s Inspection Strategy for 2018: How it Will Impact Your Company
CDRH s Inspection Strategy for 2018: How it Will Impact Your Company CAPT Sean M. Boyd, MPH, USPHS Deputy Director for Regulatory Affairs CDRH Office of Compliance Patients are at the Heart of What We
More informationFranciscan Missionaries of Our Lady Health System (FMOLHS) UDI Capture Case Study:
LEARNING UDI COMMUNITY Franciscan Missionaries of Our Lady Health System (FMOLHS) UDI Capture Case Study: Automation of Product Data Capture in the Electronic Health Record WWW.AHRMM.ORG / LUC WORK GROUP
More informationHere's Why Medtech Firms Need to Harness Technology And Now
Here's Why Medtech Firms Need to Harness Technology And Now Posted in Medical Device Business by MDDI Staff on October 23, 2014 To thrive in a new medtech marketplace, harness technology in service of
More informationUnique Device Identification. Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration
Unique Device Identification Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration jay.crowley@fda.hhs.gov 301-980-1936 Device Information Lifecycle Manufacturer Reuse Reorder Reimbursement
More informationUSTGlobal. Big Data Analysis Revolutionizing Healthcare Industry
USTGlobal Big Data Analysis Revolutionizing Healthcare Industry UST Global Inc, October 2017 Table of Contents Introduction The latest trends in healthcare point towards digitalizing the industry, with
More informationDisclosures. Laboratory Stakeholders. IVD vs. LDT. FDA Regulation of Laboratory Developed Tests 10/2/2015. FDA Regulation of LDTs
Disclosures FDA Regulation of Laboratory Developed Tests Beaumont Health System, 24 th Annual Symposium on Molecular Pathology September 16, 2015 Roger D. Klein, MD JD Director, Molecular Pathology Clinical
More informationUDI (Unique Device Identification) and patient safety latest regulatory developments
UDI (Unique Device Identification) and patient safety latest regulatory developments Ulrike Kreysa, VP Healthcare, GS1 Global Office Medical Devices Innovation Program Munich, 14 October 2016 Agenda UDI
More informationClinical Information Interoperability Council (CIIC) Providing a Shared Repository of Detailed Clinical Models for all of Health and Healthcare
Clinical Information Interoperability Council (CIIC) Providing a Shared Repository of Detailed Clinical Models for all of Health and Healthcare NIH HCS Collaboratory and PCORnet December 1, 2017 Stanley
More informationMarch 5, Discussion Guide
March 5, 2014 Discussion Guide Biomedical Innovation: Identifying Challenges and Prioritizing Needs in Medical Device Research and Development Introduction Medical device innovation in the United States
More informationKorea UDI Introduction
Korea UDI Introduction to Medical Devices Myoung Shim Kim Sr. RA Manager, Johnson & Johnson Medical Korea Why UDI Korea UDI Regulation Implementation Expectations The Vision of Global Traceability labeler
More informationQuality Measurement to Enhance Care
Quality Measurement to Enhance Care National Association of Medicaid Directors Fall Conference November 12, 2013 Rachel Nuzum, Vice President Federal & State Policy The Commonwealth Fund A Private Foundation
More information2018 Data Science Summit: The Economics Of Artificial Intelligence In Healthcare
May 30, 2018 2018 Data Science Summit: The Economics Of Artificial Intelligence In Healthcare Making AI Work In Clinical Practice Bibb Allen, MD FACR Chief Medical Officer ACR Data Science Institute OVERVIEW
More informationA Wholesaler s Point of View on UDI
A Wholesaler s Point of View on UDI Welcome to San Francisco Overview Advancing the healthcare industry for more than 180 years. Innovation, technology and process knowledge gives our customers and partners
More informationEmerging Impacts on Artificial Intelligence on Healthcare IT Session 300, February 20, 2017 James Golden, Ph.D., Christopher Ross, MBA
Emerging Impacts on Artificial Intelligence on Healthcare IT Session 300, February 20, 2017 James Golden, Ph.D., Christopher Ross, MBA 1 STEPS This presentation will meet all of the HIMSS IT Value STEPS.
More informationEnabling Healthier Populations Through the Immunization Integration Program
Enabling Healthier Populations Through the Immunization Integration Program Tuesday, February 21, 2017 1:30-2:30 p.m. Interoperability Showcase Theater [OCCC, Tangerine Ballroom] DISCLAIMER: The views
More informationWhitepaper. Tackling Complex Data Challenges in Healthcare Analytics.
Whitepaper Tackling Complex Data Challenges in Healthcare Analytics Introduction: In recent years, healthcare organizations have grown increasingly aware of the potential beneficiary uses of the data which
More informationNESTcc Call for Concepts Public Webinar. Rachael L. Fleurence, PhD. NESTcc Executive Director January 4, 2018
Dial-In: +1-415-655-0002 Access code: 662 348 083 Join Online: https://mdic.webex.com/mdic/ onstage/g.php?mtid=edc86dc3 ee6a3970422222c725600570b NESTcc Call for Concepts Public Webinar Rachael L. Fleurence,
More informationMedtec Ireland. Joint Presentation: Role of standards to support post market surveillance. GS1 Ireland 5 th October 2017
Medtec Ireland Joint Presentation: Role of standards to support post market surveillance GS1 Ireland 5 th October 2017 Disclaimer Neither GS1 nor its member organizations nor their staffs have real or
More informationREVENUE CYCLE TECHNOLOGY TRENDS
REVENUE CYCLE TECHNOLOGY TRENDS A survey of provider executives about revenue cycle IT budgets, EHRs, and consumer self-pay November 2018 Lead. Solve. Grow. HFMA/Navigant Survey At-a-Glance According to
More informationData as the key understanding all the options for business improvement Panel
Data as the key understanding all the options for business improvement Panel Mark Brommeyer, Manager Supply Chain, NEHTA Richard Bowen, Manager Data Systems and Reporting, HPV Steve Capel, Director Global
More informationCDRH Device Approval
CDRH Device Approval Mary S. Pastel, ScD Deputy Director for Radiological Health Office of In Vitro Diagnostics and Radiological Health (OIR) Center for Devices and Radiological Health (CDRH) US Food and
More information